Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

Similar articles for PubMed (Select 19587043)

1.

Influenza virus directly infects human natural killer cells and induces cell apoptosis.

Mao H, Tu W, Qin G, Law HK, Sia SF, Chan PL, Liu Y, Lam KT, Zheng J, Peiris M, Lau YL.

J Virol. 2009 Sep;83(18):9215-22. doi: 10.1128/JVI.00805-09. Epub 2009 Jul 8.

2.

Inhibition of human natural killer cell activity by influenza virions and hemagglutinin.

Mao H, Tu W, Liu Y, Qin G, Zheng J, Chan PL, Lam KT, Peiris JS, Lau YL.

J Virol. 2010 May;84(9):4148-57. doi: 10.1128/JVI.02340-09. Epub 2010 Feb 17.

3.

[Elimination of influenza virus-infected cells by phagocytosis].

Shiratsuchi A, Nakanishi Y.

Yakugaku Zasshi. 2006 Dec;126(12):1245-51. Review. Japanese.

4.

Characterization of age-related changes in natural killer cells during primary influenza infection in mice.

Nogusa S, Ritz BW, Kassim SH, Jennings SR, Gardner EM.

Mech Ageing Dev. 2008 Apr;129(4):223-30. doi: 10.1016/j.mad.2008.01.003. Epub 2008 Jan 20.

PMID:
18304606
5.

Influenza A virus H5N1 entry into host cells is through clathrin-dependent endocytosis.

Wang H, Jiang C.

Sci China C Life Sci. 2009 May;52(5):464-9. doi: 10.1007/s11427-009-0061-0. Epub 2009 May 27.

PMID:
19471869
6.

Epstein-Barr virus infection of human natural killer cell lines and peripheral blood natural killer cells.

Isobe Y, Sugimoto K, Yang L, Tamayose K, Egashira M, Kaneko T, Takada K, Oshimi K.

Cancer Res. 2004 Mar 15;64(6):2167-74.

7.

Porcine innate and adaptative immune responses to influenza and coronavirus infections.

Charley B, Riffault S, Van Reeth K.

Ann N Y Acad Sci. 2006 Oct;1081:130-6. Review.

PMID:
17135502
8.
9.

T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus.

He XS, Draghi M, Mahmood K, Holmes TH, Kemble GW, Dekker CL, Arvin AM, Parham P, Greenberg HB.

J Clin Invest. 2004 Dec;114(12):1812-9.

10.

Host cellular signaling induced by influenza virus.

Dai X, Zhang L, Hong T.

Sci China Life Sci. 2011 Jan;54(1):68-74. doi: 10.1007/s11427-010-4116-z. Epub 2011 Jan 21.

PMID:
21253874
11.

NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection.

Draghi M, Pashine A, Sanjanwala B, Gendzekhadze K, Cantoni C, Cosman D, Moretta A, Valiante NM, Parham P.

J Immunol. 2007 Mar 1;178(5):2688-98.

12.
13.
14.

Up-regulation of NK cytotoxic activity via IL-15 induction by different viruses: a comparative study.

Fawaz LM, Sharif-Askari E, Menezes J.

J Immunol. 1999 Oct 15;163(8):4473-80.

15.

Defense mechanisms against influenza virus infection in the respiratory tract mucosa.

Tamura S, Kurata T.

Jpn J Infect Dis. 2004 Dec;57(6):236-47. Review.

16.

Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung.

Small CL, Shaler CR, McCormick S, Jeyanathan M, Damjanovic D, Brown EG, Arck P, Jordana M, Kaushic C, Ashkar AA, Xing Z.

J Immunol. 2010 Feb 15;184(4):2048-56. doi: 10.4049/jimmunol.0902772. Epub 2010 Jan 18.

17.

Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses.

Welliver TP, Garofalo RP, Hosakote Y, Hintz KH, Avendano L, Sanchez K, Velozo L, Jafri H, Chavez-Bueno S, Ogra PL, McKinney L, Reed JL, Welliver RC Sr.

J Infect Dis. 2007 Apr 15;195(8):1126-36. Epub 2007 Mar 9.

18.

Alterations in receptor binding properties of recent human influenza H3N2 viruses are associated with reduced natural killer cell lysis of infected cells.

Owen RE, Yamada E, Thompson CI, Phillipson LJ, Thompson C, Taylor E, Zambon M, Osborn HM, Barclay WS, Borrow P.

J Virol. 2007 Oct;81(20):11170-8. Epub 2007 Aug 1.

19.

Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection.

Stein-Streilein J, Bennett M, Mann D, Kumar V.

J Immunol. 1983 Dec;131(6):2699-704.

PMID:
6644021
20.

Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).

Gattoni A, Parlato A, Vangieri B, Bresciani M, Derna R.

Clin Ter. 2006 Jul-Aug;157(4):377-86. Review. Retraction in: Clin Ter. 2008 May-Jun;159(3):207.

PMID:
17051976
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk